GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Curiox Biosystems Co Ltd (XKRX:445680) » Definitions » Altman Z-Score

Curiox Biosystems Co (XKRX:445680) Altman Z-Score : 10.04 (As of Apr. 23, 2025)


View and export this data going back to 2023. Start your Free Trial

What is Curiox Biosystems Co Altman Z-Score?

The Altman Z-Score is a model designed to predict the likelihood of a company going bankrupt within the next two years. Created by American finance professor Edward Altman in 1968, the model is specifically designed for publicly traded manufacturing companies with assets greater than $1 million.

Good Sign:

Altman Z-score of 9.51 is strong.

Curiox Biosystems Co has a Altman Z-Score of 10.04, indicating it is in Safe Zones. This implies the Altman Z-Score is strong.

The zones of discrimination were as such:

When Altman Z-Score <= 1.8, it is in Distress Zones.
When Altman Z-Score >= 3, it is in Safe Zones.
When Altman Z-Score is between 1.8 and 3, it is in Grey Zones.

The historical rank and industry rank for Curiox Biosystems Co's Altman Z-Score or its related term are showing as below:

XKRX:445680' s Altman Z-Score Range Over the Past 10 Years
Min: 7.05   Med: 27.57   Max: 48.09
Current: 9.51

During the past 6 years, Curiox Biosystems Co's highest Altman Z-Score was 48.09. The lowest was 7.05. And the median was 27.57.


Curiox Biosystems Co Altman Z-Score Historical Data

The historical data trend for Curiox Biosystems Co's Altman Z-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curiox Biosystems Co Altman Z-Score Chart

Curiox Biosystems Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Altman Z-Score
Get a 7-Day Free Trial - - - 48.09 7.05

Curiox Biosystems Co Quarterly Data
Dec19 Dec20 Dec21 Mar22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Altman Z-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.09 44.90 56.43 5.37 7.05

Competitive Comparison of Curiox Biosystems Co's Altman Z-Score

For the Medical Devices subindustry, Curiox Biosystems Co's Altman Z-Score, along with its competitors' market caps and Altman Z-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curiox Biosystems Co's Altman Z-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Curiox Biosystems Co's Altman Z-Score distribution charts can be found below:

* The bar in red indicates where Curiox Biosystems Co's Altman Z-Score falls into.


;
;

Curiox Biosystems Co Altman Z-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Curiox Biosystems Co's Altman Z-Score for today is calculated with this formula:

Z=1.2*X1+1.4*X2+3.3*X3+0.6*X4+1.0*X5
=1.2*0.175+1.4*-0.759+3.3*-0.1034+0.6*18.6129+1.0*0.065
=10.04

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z-Score when X4 or X5 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2024:
Total Assets was ₩70,561 Mil.
Total Current Assets was ₩32,267 Mil.
Total Current Liabilities was ₩19,918 Mil.
Retained Earnings was ₩-53,556 Mil.
Pre-Tax Income was 1692.217 + -4054.726 + -2838.741 + -2794.571 = ₩-7,996 Mil.
Interest Expense was -402.916 + -280.715 + -9.267 + -9.127 = ₩-702 Mil.
Revenue was 955.962 + 951.467 + 1092.692 + 1587.516 = ₩4,588 Mil.
Market Cap (Today) was ₩408,052 Mil.
Total Liabilities was ₩21,923 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(32266.788 - 19917.655)/70560.574
=0.175

X2=Retained Earnings/Total Assets
=-53555.514/70560.574
=-0.759

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(-7995.821 - -702.025)/70560.574
=-0.1034

X4=Market Value Equity/Book Value of Total Liabilities
=Market Cap/Total Liabilities
=408052.308/21923.092
=18.6129

X5=Revenue/Total Assets
=4587.637/70560.574
=0.065

The zones of discrimination were as such:

Distress Zones - 1.81 < Grey Zones < 2.99 - Safe Zones

Curiox Biosystems Co has a Altman Z-Score of 10.04 indicating it is in Safe Zones.

Study by Altman found that companies that are in Distress Zone have more than 80% of chances of bankruptcy in two years.


Curiox Biosystems Co  (XKRX:445680) Altman Z-Score Explanation

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4, Market Value of Equity/Book Value of Total Liabilities (MVE/TL): The measure shows how much the firm's assets can decline in value (measured by market value of equity plus debt) before the liabilities exceed the assets and the firm becomes insolvent.

X5, Revenue/Total Assets (S/TA): The capital-turnover ratio is a standard financial ratio illustrating the sales generating ability of the firm's assets.

Read more about Altman Z-Score and the original research.


Be Aware

Altman Z-Score does not apply to financial companies.


Curiox Biosystems Co Altman Z-Score Related Terms

Thank you for viewing the detailed overview of Curiox Biosystems Co's Altman Z-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Curiox Biosystems Co Business Description

Traded in Other Exchanges
N/A
Address
Samsung Harrington IT Tower, 204-213, 202, 2nd Floor, 9 Gil 41 Digital-Ro, Geumchun-Gu, Seoul, KOR, 08511
Curiox Biosystems Co Ltd is Korean Based company which brings together decades of scientific and engineering expertise in surface chemistry and life science instrumentation with the goal of overcoming critical challenges that slow the pace of life science research. The company has introduced Laminar Wash technology, which automates cell processing and enables highly reproducible and high-throughput cell analysis. The company offers various products such as LAMINAR WASH AUTO 1000 SYSTEM, Curiox Laminar Wash HT2000 System and Laminar Wash MINI System.

Curiox Biosystems Co Headlines

No Headlines